The Institute of Reconstructive Neurobiology (Head: Prof. O. Brüstle) at the University of Bonn Medical Center focuses on the use of pluripotent stem cells for the study and treatment of neurological disorders. Based on a broad technology portfolio including cell reprogramming, neural differentiation, direct cell fate conversion, stem cell industrialization and neurotransplantation, the Institute develops stem cell-based model systems for disease-related research and drug development as well as novel cell therapy regimens. It closely interacts with LIFE & BRAIN GmbH, a translational hub of the University of Bonn providing stem cell products and services for pharma, biotech and academia.
Key staff involved in EBiSC
Prof. Oliver Brüstle – Oliver Brüstle is Professor of Reconstructive Neurobiology at the University of Bonn. He is also Co-Founder and Scientific Director of LIFE & BRAIN GmbH, a biomedical enterprise serving as translational hub of the University of Bonn Medical Center. Trained as an M.D., Oliver Brüstle conducted research and clinical work in neuropathology and neurosurgery at the universities of Zurich and Erlangen, respectively. From 1993 to 1997 he worked as postdoctoral fellow at the National Institutes of Neurological Disorders and Stroke in Bethesda, MD, USA. Upon his return to Germany, he started is own lab and, in 2002, became director of the newly founded Institute of Reconstructive Neurobiology. His field of interest is stem cell research with a particular focus stem cell-based disease modeling and nervous system repair. In 2013, Brüstle was elected founding president of the German Stem Cell Network. He also serves as Chair of the Managing Board of the Stem Cell Network North Rhine Westphalia.
Michael Peitz, PhD – Michael Peitz is a postdoctoral scientist leading the reprogramming platform at the Institute of Reconstructive Neurobiology. He has long-standing expertise in the biology of pluripotent stem cells and oversees a number of neurological disease modeling projects. Dr. Peitz holds a PhD in Biology. His main area of research is iPS cell-based disease modeling of neurological disorders.
More information: http://www.meb.uni-bonn.de/rnb/ »